Provided by Tiger Trade Technology Pte. Ltd.

GENSCRIPT BIO

36.180
+2.3006.79%
Volume:15.17M
Turnover:541.65M
Market Cap:79.52B
PE:-18.78
High:36.380
Open:34.000
Low:34.000
Close:33.880
52wk High:36.380
52wk Low:10.360
Shares:2.20B
HK Float Shares:2.20B
Volume Ratio:3.54
T/O Rate:0.69%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.927
ROE:-15.33%
ROA:1.54%
PB:2.61
PE(LYR):-18.78
PS:12.00

Loading ...

Stock Track | GENSCRIPT BIO Soars 5.08% Intraday on Underlying Sales Growth and European mRNA Expansion

Stock Track
·
Mar 17

Genscript’s 2025 Profit Swing And mRNA Expansion Might Change The Case For Investing In Genscript Biotech (SEHK:1548)

Simply Wall St.
·
Mar 17

BRIEF-Genscript Biotech Corp Reports Strong Fy2025 Results As Integrated Platform Strategy And Global Execution Drive High-Quality Growth

Reuters
·
Mar 16

Genscript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth

THOMSON REUTERS
·
Mar 16

GENSCRIPT BIO (01548.HK) Announces Company Secretary Transition: Sophie Lam Appointed, Wai Ling Wong Resigns

Bulletin Express
·
Mar 15

GENSCRIPT BIO (01548) Appoints New Company Secretary

Stock News
·
Mar 15

GenScript Biotech appoints Lam Wai Yee Sophie as company secretary, replacing Wong Wai Ling

Reuters
·
Mar 15

GenScript Biotech FY2025 adjusted net profit tripled to USD 230.35 million, revenue rose 61% to USD 959.53 million

Reuters
·
Mar 15

Morgan Stanley Adjusts GENSCRIPT BIO (01548) Target Price to HK$16.5, Keeps "Overweight" Stance

Stock News
·
Mar 11

Genscript Biotech Forecasts 2025 Loss

MT Newswires Live
·
Mar 11

GENSCRIPT BIO (01548) Issues Profit Warning: FY2025 Swings to Up to US$585.60 Million Loss Despite Tripling Adjusted Net Profit

Bulletin Express
·
Mar 10

GENSCRIPT BIO Issues Profit Warning, Anticipates $506-586 Million Loss for 2025 Fiscal Year

Stock News
·
Mar 10

GenScript Biotech expects FY2025 adjusted net profit of USD 207.3-241.9 million

Reuters
·
Mar 10

Genscript Biotech - Adj Net Profit for FY2025 Expected at US$207.3 Mln-US$241.9 Mln

THOMSON REUTERS
·
Mar 10